165 related articles for article (PubMed ID: 30531551)
21. Antipsychotics for delirium.
Lonergan E; Britton AM; Luxenberg J; Wyller T
Cochrane Database Syst Rev; 2007 Apr; (2):CD005594. PubMed ID: 17443602
[TBL] [Abstract][Full Text] [Related]
22. Lower risk for tardive dyskinesia associated with second-generation antipsychotics: a systematic review of 1-year studies.
Correll CU; Leucht S; Kane JM
Am J Psychiatry; 2004 Mar; 161(3):414-25. PubMed ID: 14992963
[TBL] [Abstract][Full Text] [Related]
23. [Use of atypical antipsychotics in Charles Perrens psychiatric hospital (Bordeaux) analysis of prescribing practices for Amisulpride, Clozapine, Olanzapine and Risperidone].
Bret P; Bonnet F; Bret MC; Jaffré A
Encephale; 2002; 28(4):329-42. PubMed ID: 12232542
[TBL] [Abstract][Full Text] [Related]
24. Safety profile of amisulpride in short- and long-term use.
Rein W; Coulouvrat C; Dondey-Nouvel L
Acta Psychiatr Scand Suppl; 2000; 400():23-7. PubMed ID: 10823308
[TBL] [Abstract][Full Text] [Related]
25. No negative symptoms in healthy volunteers after single doses of amisulpride, aripiprazole, and haloperidol: a double-blind placebo-controlled trial.
Park CH; Park TW; Yang JC; Lee KH; Huang GB; Tong Z; Park MS; Chung YC
Int Clin Psychopharmacol; 2012 Mar; 27(2):114-20. PubMed ID: 22241281
[TBL] [Abstract][Full Text] [Related]
26. Hyperprolactinemia and possibly related development of prolactinoma during amisulpride treatment; three cases.
Akkaya C; Kaya B; Kotan Z; Sarandol A; Ersoy C; Kirli S
J Psychopharmacol; 2009 Aug; 23(6):723-6. PubMed ID: 18562408
[TBL] [Abstract][Full Text] [Related]
27. Choline acetyltransferase expression in rat prefrontal cortex and hippocampus after acute and chronic exposure to amisulpride, haloperidol, and risperidone.
Huang GB; Zhao T; Li CR; Sui ZY; Kang NI; Han EH; Chung YC
Neurosci Lett; 2012 Oct; 528(2):131-6. PubMed ID: 22999925
[TBL] [Abstract][Full Text] [Related]
28. An open, large, 6-month naturalistic study of outcome in schizophrenic outpatients, treated with olanzapine.
Krzystanek M; Krupka-Matuszczyk I
Hum Psychopharmacol; 2011 Jan; 26(1):81-5. PubMed ID: 23055416
[TBL] [Abstract][Full Text] [Related]
29. Effectiveness of antipsychotic treatments for schizophrenia: interim 6-month analysis from a prospective observational study (IC-SOHO) comparing olanzapine, quetiapine, risperidone, and haloperidol.
Dossenbach M; Erol A; el Mahfoud Kessaci M; Shaheen MO; Sunbol MM; Boland J; Hodge A; O'Halloran RA; Bitter I;
J Clin Psychiatry; 2004 Mar; 65(3):312-21. PubMed ID: 15096069
[TBL] [Abstract][Full Text] [Related]
30. Antipsychotic drug use and the risk of seizures: follow-up study with a nested case-control analysis.
Bloechliger M; Rüegg S; Jick SS; Meier CR; Bodmer M
CNS Drugs; 2015 Jul; 29(7):591-603. PubMed ID: 26242478
[TBL] [Abstract][Full Text] [Related]
31. Retrospective cohort study of diabetes mellitus and antipsychotic treatment in a geriatric population in the United States.
Feldman PD; Hay LK; Deberdt W; Kennedy JS; Hutchins DS; Hay DP; Hardy TA; Hoffmann VP; Hornbuckle K; Breier A
J Am Med Dir Assoc; 2004; 5(1):38-46. PubMed ID: 14706127
[TBL] [Abstract][Full Text] [Related]
32. Drug-induced parkinsonism: Revisiting the epidemiology using the WHO pharmacovigilance database.
de Germay S; Montastruc F; Carvajal A; Lapeyre-Mestre M; Montastruc JL
Parkinsonism Relat Disord; 2020 Jan; 70():55-59. PubMed ID: 31865063
[TBL] [Abstract][Full Text] [Related]
33. Frequency of sexual dysfunction and other reproductive side-effects in patients with schizophrenia treated with risperidone, olanzapine, quetiapine, or haloperidol: the results of the EIRE study.
Bobes J; Garc A-Portilla MP; Rejas J; Hern Ndez G; Garcia-Garcia M; Rico-Villademoros F; Porras A
J Sex Marital Ther; 2003; 29(2):125-47. PubMed ID: 12623765
[TBL] [Abstract][Full Text] [Related]
34. Risk of Mortality Among Patients Treated With Antipsychotic Medications: A Nationwide Population-Based Study in Taiwan.
Wang LJ; Lee SY; Yuan SS; Yang KC; Yang CJ; Lee TL; Shyu YC
J Clin Psychopharmacol; 2016 Feb; 36(1):9-17. PubMed ID: 26658260
[TBL] [Abstract][Full Text] [Related]
35. Prolactin and macroprolactin levels in psychiatric patients receiving atypical antipsychotics: A preliminary study.
Park YM; Lee SH; Lee BH; Lee KY; Lee KS; Kang SG; Lee HY; Kim W
Psychiatry Res; 2016 May; 239():184-9. PubMed ID: 27010188
[TBL] [Abstract][Full Text] [Related]
36. Haematologic malignancies associated with clozapine
Chrétien B; Lelong-Boulouard V; Chantepie S; Sassier M; Bertho M; Brazo P; Humbert X; Alexandre J; Fedrizzi S; Dolladille C
Psychol Med; 2021 Jul; 51(9):1459-1466. PubMed ID: 32036793
[TBL] [Abstract][Full Text] [Related]
37. Tardive dyskinesias and antipsychotics: a review.
Llorca PM; Chereau I; Bayle FJ; Lancon C
Eur Psychiatry; 2002 May; 17(3):129-38. PubMed ID: 12052573
[TBL] [Abstract][Full Text] [Related]
38. Diabetic ketoacidosis associated with antipsychotic drugs: case reports and a review of literature.
Vuk A; Kuzman MR; Baretic M; Osvatic MM
Psychiatr Danub; 2017 Jun; 29(2):121-135. PubMed ID: 28636569
[TBL] [Abstract][Full Text] [Related]
39. Risperidone treatment in elderly patients with dementia: relative risk of cerebrovascular events versus other antipsychotics.
Finkel S; Kozma C; Long S; Greenspan A; Mahmoud R; Baser O; Engelhart L
Int Psychogeriatr; 2005 Dec; 17(4):617-29. PubMed ID: 16202186
[TBL] [Abstract][Full Text] [Related]
40. Weight gain in patients with schizophrenia treated with risperidone, olanzapine, quetiapine or haloperidol: results of the EIRE study.
Bobes J; Rejas J; Garcia-Garcia M; Rico-Villademoros F; García-Portilla MP; Fernández I; Hernández G;
Schizophr Res; 2003 Jul; 62(1-2):77-88. PubMed ID: 12765747
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]